In a remarkable resurgence of North Africa's largest equity market, the Casablanca Stock Exchange has recently witnessed a significant initial public offering (IPO) just eight months after Morocco's inaugural fintech listing garnered unprecedented demand. T2S Group Holding, an integrated medical technology firm based in Morocco, marked its trading debut on Monday following an astonishing oversubscription rate of 43.75 times, accumulating more than 48.12 billion dirhams (approximately $5.14 billion) in orders from over 111,000 investors. This overwhelming interest resulted in retail and institutional subscribers receiving an average allocation rate of only 2.29 percent, highlighting the high demand for shares in the company.
The IPO, valued at 1.1 billion dirhams ($117 million), includes a capital increase of 350 million dirhams and a secondary sale of existing shares amounting to 750 million dirhams. Notably, this offering is the first listing of 2026 on the Casablanca bourse, following the successful December 2025 debut of Cash Plus, a Moroccan fintech that raised $82.5 million at a valuation of $550 million and was oversubscribed 64 times. Nasser Seddiqi, the chief executive of the Casablanca Stock Exchange, emphasized the significance of this IPO during the listing ceremony, noting that over 110,000 investors expressed interest in becoming shareholders of T2S, with demand exceeding the number of shares offered by more than 43 times.
The consecutive tech listings represent a pivotal shift for a stock exchange that had not seen a major technology IPO for years prior to 2025. Cash Plus was the first fintech to list on the exchange, while T2S now holds the distinction of being the first MedTech group to go public since the oversubscribed IPO of healthcare company Vicenne in July 2025. Established in 1992 by Abderraouf Sordo, T2S specializes in supplying medical equipment, diagnostic systems, radiopharmaceutical products, and hospital software. The group operates through four subsidiaries and employs over 400 individuals while collaborating with more than 40 international MedTech companies, including well-known names such as GE HealthCare, BioMérieux, Accuray, and Boston Scientific. In 2025, T2S reported revenue of 1.76 billion dirhams ($188 million) and a net profit of 211 million dirhams ($22.5 million), with projections indicating revenue growth to 4.17 billion dirhams ($445 million) by 2030 and net profit rising to 607 million dirhams ($64.8 million).
The proceeds from the IPO are earmarked for the establishment of a second cyclotron facility in Fez, the deployment of diagnostic equipment, IT system upgrades, and investments in cybersecurity. Additionally, T2S is pursuing expansion opportunities in sub-Saharan Africa, with new oncology projects slated for Côte d’Ivoire, Mali, and Senegal, already operating in over 20 African countries. The offering comprised 4.93 million shares priced at 223 dirhams each, placing the company's valuation at approximately 4.86 billion dirhams ($519 million). Following the listing, the free float will represent around 22.6 percent of the company, while existing controlling shareholders will remain bound by lock-up agreements.
Dominance of Retail Investors
One of the most notable aspects of the T2S IPO was the overwhelming participation of individual investors. Out of the 111,149 subscribers, an astounding 110,015 were natural persons, constituting nearly 99 percent of the total participants. This diverse group represented 81 different nationalities, showcasing both local enthusiasm and an increasing international interest in Moroccan equities. The Casablanca-Settat region led the way with nearly 54,000 subscribers, followed by Rabat-Salé with around 18,000, and Fès-Meknès with approximately 10,900. Younès Benjelloun, chief executive of CFG Bank, which served as the financial adviser and global coordinator for the transaction, noted that the number of retail participants positions the T2S IPO among the three largest in recent Moroccan market history by subscriber count, following SGTM and Maroc Telecom. In contrast, institutional investors, numbering just 1,134, accounted for nearly 60 percent of the shares requested by value.
The listing of Cash Plus in December 2025 set a new standard for North African fintechs, operating a hybrid “phygital” model that combines physical branches with a digital Super App catering to 2 million users, achieving a valuation of $550 million upon listing. The $82.5 million IPO was structured as a combination of growth capital and shareholder liquidity, facilitating a partial exit for private equity firm Mediterrania Capital Partners while the founding Amar and Tazi families retained their full share count and committed to a seven-year lock-up period. The offering attracted 80,759 subscribers, with 50 percent being first-time stock market investors. Demand reached 244.1 million shares against a mere 3.8 million allocated, with total subscriptions amounting to 48.8 billion dirhams ($5.2 billion), and 17 percent of subscribers were from abroad, including investors from the UK, US, France, Germany, and Senegal. Cash Plus began trading on December 8, 2025, under the ticker CAP, ranking 34th out of 79 listed companies by market capitalization. The company has pledged to distribute 85 percent of net profits as dividends annually from 2026 to 2030, establishing itself as a yield play in a market traditionally dominated by cyclical and commodity-linked stocks.
The recent tech IPOs signify broader structural changes within Morocco's capital markets. After a prolonged period of inactivity, 2025 experienced a revival with three IPOs: Vicenne in July, Cash Plus in November, and construction group SGTM. T2S has now extended this momentum into 2026. The Casablanca Stock Exchange's ability to attract two prominent technology IPOs within a single year—from sectors as varied as fintech and medical technology—indicates the maturation of Morocco’s equity market. As investors look ahead, the pressing question remains whether the pipeline of large private companies seeking public capital can be sustained. T2S commenced trading on Monday with a theoretical opening price of 301.05 dirhams, significantly higher than the reference price of 223 dirhams. Initial trading activity has suggested strong demand, although market participants will be closely monitoring for indications of post-IPO price stabilization. For the time being, the message emanating from Casablanca is unmistakable: after years of stagnation, Morocco's stock market is back, with technology firms leading the way.
As reported by launchbaseafrica.com.
